Stroke research in China

Neurological Research

Volumn 28, Issue 1, 2006, Pages 11-15

  Wei, Gangzhi ^a   Ji, Xunming ^a   Bai, Hua ^b   Ding, Yuchuan ^c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Cerebral; Chinese traditional drug; Hemorrhage; Ischemia

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ASTRAGALOSIDE IV EXTRACT; BATROXOBIN; BUYANG HUANWU EXTRACT; CHINESE DRUG; CLAUSENAMIDE; CYCLOSPORIN A; FLAVONOID; HERBACEOUS AGENT; IMMUNOSUPPRESSIVE AGENT; IPTAKALIM; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NAOXINQING; NEUROPROTECTIVE AGENT; UNCLASSIFIED DRUG; UROKINASE;

BRAIN INFARCTION; BRAIN ISCHEMIA; CADASIL; CHINA; CHINESE; CHINESE MEDICINE; CLINICAL RESEARCH; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; EPIDEMIOLOGICAL DATA; GENETIC EPIDEMIOLOGY; HUMAN; LEUKOENCEPHALOPATHY; MEDICAL RESEARCH; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; REVIEW; STROKE; TISSUE PERFUSION; TREATMENT FAILURE; TREATMENT OUTCOME;

ANIMALS; BIOMEDICAL RESEARCH; CEREBROVASCULAR ACCIDENT; CHINA; HUMANS;

EID: 32044453348     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164106X91807     Document Type: Review

References (38)

1. Zhang LF, Yang J, Hong Z, et al. Collaborative group of China multicenter study of cardiovascular epidemiology. Proportion of different subtypes of stroke in China. Stroke 2003; 34: 2091-2096
2. Yang QD, Niu Q, Zhou YH, et al. Incidence of cerebral hemorrhage in the Changsha community. A prospective study from 1986 to 2000. Cerebrovasc Dis 2004; 17: 303-313
3. Gong T, Wang X. Long-term follow-up study of 72 patients with transient ischemic attacks. Chin Med J (Engl) 2001; 114: 1270-1272
4. Jia JP, Jia JM, Zhou WD, et al. Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia. Chin Med J (Engl) 2004; 117: 1161-1164
5. Stone S. Stroke units. Every patient with a stroke should be treated in a stroke unit. BMJ 2002; 325: 291-292
6. Ma RH, Wang YJ, Qu H, et al. Assessment of the early effectiveness of a stroke unit in comparison to the general ward. Chin Med J (Engl) 2004; 117: 852-855
7. Bai H, Wei GZ. Studies on the feature and pathogenesis of 82 cases with moyamoya diseases. Chin J Neurol 2002; 35: 318
8. Li Z, Sun L, Zhang H, et al. Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: A Multicenter case-control study in China. Stroke 2003; 34: 2085-2090
9. Xia J, Yang QD, Yang QM, et al. Apolipoprotein H gene polymorphisms and risk of primary cerebral hemorrhage in a Chinese population. Cerebrovasc Dis 2004; 17: 197-203
10. Jin ZQ, Fan YS, Ding J, et al. Association of apolipoprotein E 4 polymorphism with cerebral infarction in Chinese Han population. Acta Pharmacol Sin 2004; 25: 352-356
11. Liu XN, Song L, Wang DW, et al. Correlation of thrombospondin-1 G1678A polymorphism to stroke: A study in Chinese population. Natl Med J Chin 2004; 84: 1959-1962
12. Zhao SP, Tong QG, Xiao ZJ, et al. The lipoprotein lipase Ser447Ter mutation and risk of stroke in the Chinese. Clin Chim Acta 2003; 330: 161-164
13. Sun L, Li Z, Zhang H, et al. Pentanucleotide TTTTA repeat polymorphism of apolipoprotein(a) gene and plasma lipoprotein(a) are associated with ischemic and hemorrhagic stroke in Chinese: A multicenter case-control study in China. Stroke 2003; 34: 1617-1622
14. Tang K, Zhang JT. Clausenamide improves long-term potentiation impairment and attenuates apoptosis after transient middle cerebral artery occlusion in rats. Neurol Res 2003; 25: 713-717
15. Yan B, Wang DY, Xing DM, et al. The antidepressant effect of ethanol extract of radix puerariae in mice exposed to cerebral ischemia reperfusion. Pharmacol Biochem Behav 2004; 78: 319-325
16. Zhang DL, Zhang YT, Yin JJ, et al. Oral administration of Crataegus flavonoids protects against ischemia/reperfusion brain damage in gerbils. J Neurochem 2004; 90: 211-219
17. Zhou JY, Dong WW. Matrix metalloproteinase-9 expression by endothelial cells incubated with peripheral blood leukocytes from patients with cerebral infarction. Natl Med J Chin 2004; 84: 979-981
18. Xie SP, Chan B, Zhang J, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: clinical, pathology and genetics. Chin J Neurol 2000; 33: 272-276
19. Wang ZX, Lu H, Zhang Y, et al. NOTCH3 gene mutations in four Chinese families with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Natl Med J Chin 2004; 84: 1175-1180
20. Yuan Y, Wang ZX, Zhang W, et al. Pathological changes of vessels in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Chin J Neurol 2005; 38: 7-10
21. Federico A, Bianchi S, Dotti MT. The spectrum of mutations for CADASIL diagnosis. Neurol Sci 2005; 26 (2): 117-124
22. Tang T, Li XQ, Wu H, et al. Activation of endogenous neural stem cells in experimental intracerebral hemorrhagic rat brains. Chin Med J (Engl) 2004; 117: 1342-1347
23. Zhang B, Wang RZ, Yao Y, et al. Proliferation and differentiation of neural stem cells in adult rats after cerebral infarction. Chin Med Sci J 2004; 19: 73-97
24. Zeng JS, Yu J, Cui CM, et al. Cultured human embryonic neocortical cells survive and grow in infarcted cavities of adult rat brains and interconnect with host brain. Chin Med J (Engl) 2005; 118: 275-280
25. Wang ZQ, Chen XC, Yang GY, et al. U0126 prevents ERK pathway phosphorylation and interleukin-1 beta mRNA production after cerebral ischemia. Chin Med Sci J 2004; 19: 270-275
26. Wang H, Zhang YL, Tang XC, et al. Targeting ischemic stroke with a novel opener of ATP-sensitive potassium channels in the brain. Mol Pharmacol 2004; 66: 1160-1168
27. Li XM, Bai XC, Qin LN, et al. Neuroprotective effects of Buyang Huanwu decoction on neuronal injury in hippocampus after transient forebrain ischemia in rats. Neurosci Lett 2003; 346: 29-32
28. Luo Y, Qin Z, Hong Z, et al. Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia. Neurosci Lett 2004; 363: 218-223
29. Bei W, Peng W, Ma Y, et al. An anti-stroke herbal medicine, reduces hydrogen peroxide-induced injury in NG108-15 cells. Neurosci Lett 2004; 363: 262-265
30. Wei GZ, Bai H. The focus and prospect of the modern treatment for cerebral infarction. Chin J Cerebrovas Dis 2004; 1: 193-195
31. Chen QT. intravenous thrombolysis with urokinase for acute cerebral infarction. Chin J Neurol 2002; 35: 210-218
32. Liu XQ. Reassessment of defibrase in treatment of cerebral infarction. Chin J Neurol 2005; 38: 11-16
33. Du JX, Lin F, Zhan YF, et al. A comparative study of the therapeutic effect on cerebral hemorrhage. Chin J Cerebrovasc Dis 2004; 1: 292-294
34. Li SM, Lin F, Mou ZY, et al. comparison study of endarterectomy and stenting on severe internal carotid stenosis. Chin J Cerebrovasc Dis 2005; 2: 56-61
35. Chen JH. Clinical observation of the element of root of kudzu vine combined with AFP on cerebral infarction. China Sino-western medicine 2003; 4: 1915-1930
36. Zhang T, Li LL, Bi S, et al. Effects of three-stage rehabilitation treatment on acute cerebrovascular diseases: A prospective, randomized, controlled, multicenter study. Natl Med J Chin 2004; 84: 1948-1954
37. Tang WK, Chan SS, Chiu HF, et al. Frequency and determinants of poststroke dementia in Chinese. Stroke 2004; 35: 930-935
38. Jiang B, Wang WZ, Wu SP, et al. Effects of urban community intervention on 3-year survival and recurrence after first-ever stroke. Stroke 2004; 35: 1242-1247